Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report

Treatment with programmed cell death 1 inhibitors is associated with a wide range of cutaneous immune-related adverse events, with lichenoid eruptions representing one of the major cutaneous toxicities. We describe the case of an 81-year-old man with metastatic melanoma treated with pembrolizumab wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Esfahani, Khashayar, Henderson Berg, Meagan-Helen, Zargham, Hanieh, Billick, Robin, Pehr, Kevin, Redpath, Margaret, Roshdy, Osama, Miller, Wilson H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996651/
https://www.ncbi.nlm.nih.gov/pubmed/33771890
http://dx.doi.org/10.1136/jitc-2020-001831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996651/
https://www.ncbi.nlm.nih.gov/pubmed/33771890
http://dx.doi.org/10.1136/jitc-2020-001831

Ejemplares similares